184 related articles for article (PubMed ID: 31502627)
1. Targeted imaging and targeted therapy of breast cancer cells via fluorescent double template-imprinted polymer coated silicon nanoparticles by an epitope approach.
Wang HY; Cao PP; He ZY; He XW; Li WY; Li YH; Zhang YK
Nanoscale; 2019 Sep; 11(36):17018-17030. PubMed ID: 31502627
[TBL] [Abstract][Full Text] [Related]
2. Highly Effective Drug Delivery and Cell Imaging Using Fluorescent Double-Imprinted Nanoparticles by Targeting Recognition of the Epitope of Membrane Protein.
Qin YT; Peng H; He XW; Li WY; Zhang YK
Anal Chem; 2019 Oct; 91(20):12696-12703. PubMed ID: 31532634
[TBL] [Abstract][Full Text] [Related]
3. Carbon dots-embedded epitope imprinted polymer for targeted fluorescence imaging of cervical cancer via recognition of epidermal growth factor receptor.
Zhang Y; Li S; Ma XT; He XW; Li WY; Zhang YK
Mikrochim Acta; 2020 Mar; 187(4):228. PubMed ID: 32170469
[TBL] [Abstract][Full Text] [Related]
4. Tumor-Sensitive Biodegradable Nanoparticles of Molecularly Imprinted Polymer-Stabilized Fluorescent Zeolitic Imidazolate Framework-8 for Targeted Imaging and Drug Delivery.
Qin YT; Feng YS; Ma YJ; He XW; Li WY; Zhang YK
ACS Appl Mater Interfaces; 2020 Jun; 12(22):24585-24598. PubMed ID: 32390415
[TBL] [Abstract][Full Text] [Related]
5. Silicon nanoparticles coated with an epitope-imprinted polymer for fluorometric determination of cytochrome c.
Zhang XM; Qin YP; Ye HL; Ma XT; He XW; Li WY; Zhang YK
Mikrochim Acta; 2018 Feb; 185(3):173. PubMed ID: 29594524
[TBL] [Abstract][Full Text] [Related]
6. Epitope Molecularly Imprinted Polymer Nanoparticles for Chemo-/Photodynamic Synergistic Cancer Therapy Guided by Targeted Fluorescence Imaging.
Peng H; Qin YT; He XW; Li WY; Zhang YK
ACS Appl Mater Interfaces; 2020 Mar; 12(11):13360-13370. PubMed ID: 32101405
[TBL] [Abstract][Full Text] [Related]
7. Preparation of Dual-Template Epitope Imprinted Polymers for Targeted Fluorescence Imaging and Targeted Drug Delivery to Pancreatic Cancer BxPC-3 Cells.
Jia C; Zhang M; Zhang Y; Ma ZB; Xiao NN; He XW; Li WY; Zhang YK
ACS Appl Mater Interfaces; 2019 Sep; 11(35):32431-32440. PubMed ID: 31393695
[TBL] [Abstract][Full Text] [Related]
8. Activatable Fluorescence Imaging and Targeted Drug Delivery via Extracellular Vesicle-Like Porous Coordination Polymer Nanoparticles.
Wu Y; Zhang F; Wang K; Luo P; Wei Y; Liu S
Anal Chem; 2019 Nov; 91(21):14036-14042. PubMed ID: 31603308
[TBL] [Abstract][Full Text] [Related]
9. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization, and biological verification of anti-HER2 indocyanine green-doxorubicin-loaded polyethyleneimine-coated perfluorocarbon double nanoemulsions for targeted photochemotherapy of breast cancer cells.
Lee YH; Ma YT
J Nanobiotechnology; 2017 May; 15(1):41. PubMed ID: 28521752
[TBL] [Abstract][Full Text] [Related]
11. Trastuzumab modified silica nanoparticles loaded with doxorubicin for targeted and synergic therapy of breast cancer.
Meng LX; Ren Q; Meng Q; Zheng YX; He ML; Sun SY; Ding ZJ; Li BC; Wang HY
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S556-S563. PubMed ID: 30146920
[TBL] [Abstract][Full Text] [Related]
12. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy.
Wang TW; Yeh CW; Kuan CH; Wang LW; Chen LH; Wu HC; Sun JS
Acta Biomater; 2017 Aug; 58():54-66. PubMed ID: 28606810
[TBL] [Abstract][Full Text] [Related]
13. Biodegradable Imprinted Polymer Based on ZIF-8/DOX-HA for Synergistically Targeting Prostate Cancer Cells and Controlled Drug Release with Multiple Responses.
Song Y; Han S; Liu S; Sun R; Zhao L; Yan C
ACS Appl Mater Interfaces; 2023 May; 15(21):25339-25353. PubMed ID: 37212295
[TBL] [Abstract][Full Text] [Related]
14. Targeting and Imaging of Cancer Cells via Monosaccharide-Imprinted Fluorescent Nanoparticles.
Wang S; Yin D; Wang W; Shen X; Zhu JJ; Chen HY; Liu Z
Sci Rep; 2016 Mar; 6():22757. PubMed ID: 26948803
[TBL] [Abstract][Full Text] [Related]
15. [Preclinical application of MR and fluorescent dual-modality imaging combined with photothermal therapy in HER-2 positive breast cancer].
Luo XJ; Li J; Zhou CW
Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):587-593. PubMed ID: 30139028
[No Abstract] [Full Text] [Related]
16. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
[TBL] [Abstract][Full Text] [Related]
17. Biocompatible mesoporous silica-coated superparamagnetic manganese ferrite nanoparticles for targeted drug delivery and MR imaging applications.
Sahoo B; Devi KS; Dutta S; Maiti TK; Pramanik P; Dhara D
J Colloid Interface Sci; 2014 Oct; 431():31-41. PubMed ID: 24980623
[TBL] [Abstract][Full Text] [Related]
18. Specific aptamer-conjugated mesoporous silica-carbon nanoparticles for HER2-targeted chemo-photothermal combined therapy.
Wang K; Yao H; Meng Y; Wang Y; Yan X; Huang R
Acta Biomater; 2015 Apr; 16():196-205. PubMed ID: 25596325
[TBL] [Abstract][Full Text] [Related]
19. Dual-Labeled Near-Infrared/(99m)Tc Imaging Probes Using PAMAM-Coated Silica Nanoparticles for the Imaging of HER2-Expressing Cancer Cells.
Yamaguchi H; Tsuchimochi M; Hayama K; Kawase T; Tsubokawa N
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399687
[TBL] [Abstract][Full Text] [Related]
20. Functionalized immunostimulating complexes with protein A via lipid vinyl sulfones to deliver cancer drugs to trastuzumab-resistant HER2-overexpressing breast cancer cells.
Rodríguez-Serrano F; Mut-Salud N; Cruz-Bustos T; Gomez-Samblas M; Carrasco E; Garrido JM; López-Jaramillo FJ; Santoyo-Gonzalez F; Osuna A
Int J Nanomedicine; 2016; 11():4777-4785. PubMed ID: 27698563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
